Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Vitreoretinal Diseases and Surgery
•
Uveitis and Ocular Immunology
How do you manage macular-threatening toxoplasma chorioretinitis in pregnancy?
Related Questions
How do you manage cystoid macular edema (CME) in patients with steroid-induced intraocular hypertension that is resistant to topical treatments?
How do you decide on when to start or continue anti-VEGF injections during pregnancy?
What is your approach to antiviral treatment of HSV acute retinal necrosis?
Do you routinely recommend IV systemic antibiotic therapy in additional to intravitreal antibiotic therapy for exogenous bacterial endophthalmitis?
How do you manage Cancer-Associated Retinopathy (CAR) in a patient who doesn’t have a known cancer diagnosis, given the difficulty in finding the underlying cancer and the risks of using immunosuppressive treatments to preserve vision?
In a patient with isolated HLA B27+ anterior uveitis, how long would you continue immunosuppressive therapy?
How do you decide between initiating systemic immunosuppressive therapy versus controlling the uveitis with local treatment in a patient with HLA-B27 positive uveitis and a history of spondyloarthropathy?
What factors guide the decision to treat with ROP laser treatment versus a repeat anti-VEGF injection in a child who has previously received anti-VEGF therapy for retinopathy of prematurity (ROP)?
Do you utilize thrombolytic therapy in patients with CRAO?
How do you approach the management of recurrent episcleritis in a patient with RA that is otherwise well-controlled?
